Opus Genetics, Inc.

Nasdaq:IRD

Pharmaceutical Preparations·DURHAM, NC

Governanceproxy statements · beneficial ownership

Proxy Statements

40 shown

Filed	Form	Description
3/12/26	PRE 14A	PRE 14A	→
4/14/25	DEFA14A	ADDITIONAL DEFINITIVE PROXY SOLICITATING MATERIALS	→
4/11/25	DEFA14A	ADDITIONAL DEFINITIVE PROXY SOLICITATING MATERIALS	→
4/10/25	DEFA14A	ADDITIONAL DEFINITIVE PROXY SOLICITATING MATERIALS	→
4/7/25	DEFA14A	ADDITIONAL DEFINITIVE PROXY MATERIAL	→
4/2/25	DEFC14A	PRELIMINARY PROXY STATEMENT	→
↓

Ownership Filings

40 shown

Filed	Form	Description
2/17/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
↓